RDL – C

Used in Prevention of ACS, MI & Ischemic Stroke

Rosuvastatin lowers LDL-C, stabilizes atherosclerotic plaques, and improves endothelial function.

Clopidogrel inhibits platelet aggregation by blocking the P2Y12 receptor, reducing the risk of thrombus formation.

Description

Rosuvastatin 5/10/20mg + Clopidogrel 75mg

Used In Secondary Prevention of ACS, MI & Ischemic Stroke

Together, they reduce plaque progression (statin effect) and plaque rupture/thrombosis (antiplatelet effect), giving synergistic protection

Available in oral Capsule form. Once Daily